Literature DB >> 10795375

Dientamoeba fragilis: the unflagellated human flagellate.

J J Windsor1, E H Johnson.   

Abstract

Dientamoeba fragilis is a pathogenic protozoan parasite with a world-wide distribution. Although originally described as an amoeboid organism, it has been reclassified as a flagellate, on the basis of a number of electron microscopic and immunological findings. Except for its lack of a flagellum, D. fragilis closely resembles Histomonas and Trichomonas. Interestingly, a resistant cyst stage has not been demonstrated and it is unlikely that its trophozoites can survive successfully outside the human host. As a consequence of its higher than anticipated coincidence of infection with Enterobius vermicularis, transmission may occur via ova of this pinworm. D. fragilis infection may be acute or chronic, and has been reported in both children and adults. The most common clinical symptoms include abdominal pain, persistent diarrhoea, loss of appetite, weight loss and flatulence. Occasionally, eosinophilia, urticaria and pruritus have been described. Demonstration of the characteristic nuclear structure of D. fragilis, needed for a definitive diagnosis, cannot be achieved in unstained faecal material; therefore, permanently stained smears are essential. Treatment is recommended in symptomatic cases, and iodoquinol, tetracycline and metronidazole have been used successfully.

Entities:  

Mesh:

Year:  1999        PMID: 10795375

Source DB:  PubMed          Journal:  Br J Biomed Sci        ISSN: 0967-4845            Impact factor:   3.829


  14 in total

1.  Blastocystis hominis and Dientamoeba fragilis in patients fulfilling irritable bowel syndrome criteria.

Authors:  Javed Yakoob; Wasim Jafri; Mohammad Asim Beg; Zaigham Abbas; Shagufta Naz; Muhammad Islam; Rustam Khan
Journal:  Parasitol Res       Date:  2010-06-08       Impact factor: 2.289

Review 2.  Dientamoeba fragilis, One of the Neglected Intestinal Protozoa.

Authors:  Lynne S Garcia
Journal:  J Clin Microbiol       Date:  2016-04-06       Impact factor: 5.948

3.  A review of the clinical presentation of dientamoebiasis.

Authors:  Damien Stark; Joel Barratt; Tamalee Roberts; Deborah Marriott; John Harkness; John Ellis
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

4.  Comparison and Recommendations for Use of Dientamoeba fragilis Real-Time PCR Assays.

Authors:  Rory Gough; John Ellis; Damien Stark
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

Review 5.  Dientamoeba fragilis, the Neglected Trichomonad of the Human Bowel.

Authors:  Damien Stark; Joel Barratt; Douglas Chan; John T Ellis
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

6.  Comparison of microscopy, two xenic culture techniques, conventional and real-time PCR for the detection of Dientamoeba fragilis in clinical stool samples.

Authors:  D Stark; J Barratt; T Roberts; D Marriott; J Harkness; J Ellis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-02-14       Impact factor: 3.267

Review 7.  Emerging from obscurity: biological, clinical, and diagnostic aspects of Dientamoeba fragilis.

Authors:  Eugene H Johnson; Jeffrey J Windsor; C Graham Clark
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

8.  Dientamoeba fragilis in Denmark: epidemiological experience derived from four years of routine real-time PCR.

Authors:  D Röser; J Simonsen; H V Nielsen; C R Stensvold; K Mølbak
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-24       Impact factor: 3.267

Review 9.  Current treatment options for Dientamoeba fragilis infections.

Authors:  Noriyuki Nagata; Deborah Marriott; John Harkness; John T Ellis; Damien Stark
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-09-03       Impact factor: 4.077

10.  Pigs as natural hosts of Dientamoeba fragilis genotypes found in humans.

Authors:  Simone M Cacciò; Anna Rosa Sannella; Elisabetta Manuali; Fabio Tosini; Marco Sensi; Daniele Crotti; Edoardo Pozio
Journal:  Emerg Infect Dis       Date:  2012-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.